BACKGROUND: Increasing evidence supports the important role of illness state and individual characteristics in insight. METHODS: Insight, as measured with the Scale to Assess Unawareness of Mental Disorder, over the first 2 years of early-onset first-episode psychosis and its correlations with clinical, socio-demographic, cognitive, and structural brain variables are studied. RESULTS: (1) insight at 2 years is poorer in schizophrenia spectrum disorders (SSDs) than in subjects with other psychoses; (2) the more severe the psychosis, the worse the insight. In SSD, depressive symptoms, poorer baseline executive functioning, lower IQ, longer duration of untreated psychosis (DUP), and poorer premorbid infancy adjustment are associated with poorer insight; frontal and parietal gray matter (GM) reductions at baseline correlate with worse insight into having psychotic symptoms at 2 years; (3) insight into having a mental disorder (Scale to Assess Unawareness of Mental Disorder [SUMD]1) at 1 year, DUP, and baseline IQ are the most consistent variables explaining different aspects of insight at 2 years in SSD patients. IQ and SUMD1 at 1 year, together with left frontal and parietal GM volumes, explain 80% of the variance of insight into having specific psychotic symptoms in SSD patients (adjusted R(2) = 0.795, F = 15.576, P < .001). CONCLUSION: Insight is a complex phenomenon that depends both on severity of psychopathology and also on disease and subject characteristics, such as past adjustment, IQ, DUP, cognitive functioning, frontal and parietal GM volumes, and age, gender, and ethnicity.
BACKGROUND: Increasing evidence supports the important role of illness state and individual characteristics in insight. METHODS: Insight, as measured with the Scale to Assess Unawareness of Mental Disorder, over the first 2 years of early-onset first-episode psychosis and its correlations with clinical, socio-demographic, cognitive, and structural brain variables are studied. RESULTS: (1) insight at 2 years is poorer in schizophrenia spectrum disorders (SSDs) than in subjects with other psychoses; (2) the more severe the psychosis, the worse the insight. In SSD, depressive symptoms, poorer baseline executive functioning, lower IQ, longer duration of untreated psychosis (DUP), and poorer premorbid infancy adjustment are associated with poorer insight; frontal and parietal gray matter (GM) reductions at baseline correlate with worse insight into having psychotic symptoms at 2 years; (3) insight into having a mental disorder (Scale to Assess Unawareness of Mental Disorder [SUMD]1) at 1 year, DUP, and baseline IQ are the most consistent variables explaining different aspects of insight at 2 years in SSDpatients. IQ and SUMD1 at 1 year, together with left frontal and parietal GM volumes, explain 80% of the variance of insight into having specific psychotic symptoms in SSDpatients (adjusted R(2) = 0.795, F = 15.576, P < .001). CONCLUSION: Insight is a complex phenomenon that depends both on severity of psychopathology and also on disease and subject characteristics, such as past adjustment, IQ, DUP, cognitive functioning, frontal and parietal GM volumes, and age, gender, and ethnicity.
Authors: N Crumlish; P Whitty; M Kamali; M Clarke; S Browne; O McTigue; A Lane; A Kinsella; C Larkin; E O'Callaghan Journal: Acta Psychiatr Scand Date: 2005-12 Impact factor: 6.392
Authors: Dominic Marjoram; Clare Gardner; Jonathan Burns; Patrick Miller; Stephen M Lawrie; Eve C Johnstone Journal: Cogn Neuropsychiatry Date: 2005-11 Impact factor: 1.871
Authors: M Mayoral; A Zabala; O Robles; I Bombín; P Andrés; M Parellada; D Moreno; M Graell; O Medina; C Arango Journal: Eur Psychiatry Date: 2008-04-08 Impact factor: 5.361
Authors: Julia M Lappin; Kevin D Morgan; Lucia R Valmaggia; Matthew R Broome; James B Woolley; Louise C Johns; Paul Tabraham; Elvira Bramon; Philip K McGuire Journal: Schizophr Res Date: 2007-01-09 Impact factor: 4.939
Authors: Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey Journal: Schizophr Res Date: 2012-03-02 Impact factor: 4.939
Authors: Philip Gerretsen; M Mallar Chakravarty; David Mamo; Mahesh Menon; Bruce G Pollock; Tarek K Rajji; Ariel Graff-Guerrero Journal: Hum Brain Mapp Date: 2012-01-03 Impact factor: 5.038
Authors: Philip Gerretsen; Mahesh Menon; David C Mamo; Gagan Fervaha; Gary Remington; Bruce G Pollock; Ariel Graff-Guerrero Journal: Schizophr Res Date: 2014-11-08 Impact factor: 4.939
Authors: Anthony S David; Nicholas Bedford; Ben Wiffen; James Gilleen Journal: Philos Trans R Soc Lond B Biol Sci Date: 2012-05-19 Impact factor: 6.237